FDA Approved: VAGIFEM — Supplemental Application (Novo Nordisk)

View source ↗

Summary

FDA approved a supplemental application for Vagifem (estradiol) from Novo Nordisk. It involves changes to the product's labeling under the supplemental pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrophic Vaginitis
• Genitourinary Syndrome of Menopause

Drugs mentioned

• Vagifem (Estradiol)

Snippet

SUPPL AP for VAGIFEM (ESTRADIOL)